UPDATE 2-Amicus Therapeutics receives U.S. approval for Fabry disease drug

0
3
Peru president expects lithium, uranium mining laws passed in 6 months



U.S. health regulators on Friday approved
Amicus Therapeutics’ Galafold, the first oral therapy
to treat Fabry disease, a rare, sometimes fatal condition in
which accumulation of fat damages several organs.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here